Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2002

View Archived Issues

Memantine induces neuroprotection in rats and is effective for treating dementia in humans

Synthesis and efficacy of two novel orally active antimalarial synthetic 3-carboxyphenyltrioxanes

Periostat enters phase III trial for the treatment of rosacea

CAT and Xerion enter allergy target research collaboration

VitrenASE enters phase II trial in proliferative vitreoretinopathy

Pivotal Alprox-TD studies complete enrollment

Growth hormone reverses thymic atrophy in HIV-infected men

Antithrombotic efficacy of MAb-LE2E9 shown in a murine model of venous thrombosis

Skin permeation of miconazole is enhanced by hydrogenated soybean lecithin and DDAIP formulations

New hypolipidemic agents emerging from Aventis R&D

New erythromycin A derivatives in early development at GSK

Lilly claims sPLA2 inhibitors with potential in sepsis and other inflammatory disorders

Selective procollagen C-proteinase inhibitors presented by Pfizer

Antioxidant epicatechin derivatives for use in cancer, cardiovascular disorders, etc.

Elidel receives positive health authority decision in 13 European countries

OSI and Genentech update progress of Tarceva development program

Results on FTase inhibitor SCH-400 presented at ACS

Merck reports novel KDR inhibitors at ACS meeting

In vitro and in vivo characterization of new KDR inhibitors disclosed by Merck

Wyeth scientists identify novel inhibitors of B7.1-CD28 interaction

New cathepsin S inhibitors designed by Boehringer Ingelheim researchers

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...